Literature DB >> 29578037

Cocaine evokes a profile of oxidative stress and impacts innate antiviral response pathways in astrocytes.

Irma E Cisneros1, Mert Erdenizmenli2, Kathryn A Cunningham3, Slobodan Paessler4, Kelly T Dineley5.   

Abstract

HIV-1 and Zika virus (ZIKV) represent RNA viruses with neurotropic characteristics. Infected individuals suffer neurocognitive disorders aggravated by environmental toxins, including drugs of abuse such as cocaine, exacerbating HIV-associated neurocognitive disorders through a combination of astrogliosis, oxidative stress and innate immune signaling; however, little is known about how cocaine impacts the progression of ZIKV neural perturbations. Impaired innate immune signaling is characterized by weakened antiviral activation of interferon signaling and alterations in inflammatory signaling, factors contributing to cognitive sequela associated with cocaine in HIV-1/ZIKV infection. We employed cellular/molecular biology techniques to test if cocaine suppresses the efficacy of astrocytes to initiate a Type 1 interferon response to HIV-1/ZIKV, in vitro. We found cocaine activated antiviral signaling pathways and type I interferon in the absence of inflammation. Cocaine pre-exposure suppressed antiviral responses to HIV-1/ZIKV, triggering antiviral signaling and phosphorylation of interferon regulatory transcription factor 3 to stimulate type I interferon gene transcription. Our data indicate that oxidative stress is a major driver of cocaine-mediated astrocyte antiviral immune responses. Although astrocyte antiviral signaling is activated following detection of foreign pathogenic material, oxidative stress and increased cytosolic double-stranded DNA (dsDNA) can drive antiviral signaling via stimulation of pattern recognition receptors. Pretreatment with the glial modulators propentofylline (PPF) or pioglitazone (PIO) reversed cocaine-mediated attenuation of astrocyte responses to HIV-1/ZIKV. Both PPF/PIO protected against cocaine-mediated generation of reactive oxygen species (ROS), increased dsDNA, antiviral signaling pathways and increased type I interferon, indicating that cocaine induces astrocyte type I interferon signaling in the absence of virus and oxidative stress is a major driver of cocaine-mediated astrocyte antiviral immunity. Lastly, PPF and PIO have therapeutic potential to ameliorate cocaine-mediated dysregulation of astrocyte antiviral immunity possibly via a myriad of protective actions including decreases in reactive phenotype and damaging immune factors. Published by Elsevier Ltd.

Entities:  

Keywords:  Astrocytes; Cocaine; HIV-1; Oxidative stress; Type I interferon; Zika virus

Mesh:

Substances:

Year:  2018        PMID: 29578037      PMCID: PMC5975185          DOI: 10.1016/j.neuropharm.2018.03.019

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  91 in total

1.  Immune system inflammation in cocaine dependent individuals: implications for medications development.

Authors:  Helen C Fox; Carrol D'Sa; Anne Kimmerling; Kristen M Siedlarz; Keri L Tuit; Raymond Stowe; Rajita Sinha
Journal:  Hum Psychopharmacol       Date:  2012-03       Impact factor: 1.672

Review 2.  Serotonin at the nexus of impulsivity and cue reactivity in cocaine addiction.

Authors:  Kathryn A Cunningham; Noelle C Anastasio
Journal:  Neuropharmacology       Date:  2013-07-11       Impact factor: 5.250

Review 3.  Endocytosis of human immunodeficiency virus 1 (HIV-1) in astrocytes: a fiery path to its destination.

Authors:  Ashok Chauhan; Mehrab Khandkar
Journal:  Microb Pathog       Date:  2014-11-04       Impact factor: 3.738

4.  The mitochondrial outer membrane protein mitoNEET is a redox enzyme catalyzing electron transfer from FMNH2 to oxygen or ubiquinone.

Authors:  Yiming Wang; Aaron P Landry; Huangen Ding
Journal:  J Biol Chem       Date:  2017-05-01       Impact factor: 5.157

Review 5.  CXCL8 as a Potential Therapeutic Target for HIV-Associated Neurocognitive Disorders.

Authors:  Manmeet K Mamik; Anuja Ghorpade
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

6.  Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways.

Authors:  Honghong Yao; James E Allen; Xuhui Zhu; Shannon Callen; Shilpa Buch
Journal:  J Neurovirol       Date:  2009-04       Impact factor: 2.643

7.  MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction.

Authors:  Jannet Kocerha; Mohammad Ali Faghihi; Miguel A Lopez-Toledano; Jia Huang; Amy J Ramsey; Marc G Caron; Nicole Sales; David Willoughby; Joacim Elmen; Henrik F Hansen; Henrik Orum; Sakari Kauppinen; Paul J Kenny; Claes Wahlestedt
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-05       Impact factor: 11.205

8.  Proteomic analysis of mitochondrial-associated ER membranes (MAM) during RNA virus infection reveals dynamic changes in protein and organelle trafficking.

Authors:  Stacy M Horner; Courtney Wilkins; Samantha Badil; Jason Iskarpatyoti; Michael Gale
Journal:  PLoS One       Date:  2015-03-03       Impact factor: 3.240

9.  HIV and Cocaine Impact Glial Metabolism: Energy Sensor AMP-activated protein kinase Role in Mitochondrial Biogenesis and Epigenetic Remodeling.

Authors:  Thangavel Samikkannu; Venkata S R Atluri; Madhavan P N Nair
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

10.  miR-146a, miR-146b, and miR-155 increase expression of IL-6 and IL-8 and support HSP10 in an In vitro sepsis model.

Authors:  Dagmar Pfeiffer; Eva Roßmanith; Ingrid Lang; Dieter Falkenhagen
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

View more
  7 in total

Review 1.  Neuroinflammation & pre-mature aging in the context of chronic HIV infection and drug abuse: Role of dysregulated autophagy.

Authors:  Ming-Lei Guo; Shilpa Buch
Journal:  Brain Res       Date:  2019-09-12       Impact factor: 3.252

2.  The Cannabinoid Receptor Agonist, WIN-55212-2, Suppresses the Activation of Proinflammatory Genes Induced by Interleukin 1 Beta in Human Astrocytes.

Authors:  Jerel Adam Fields; Mary K Swinton; Patricia Montilla-Perez; Eugenia Ricciardelli; Francesca Telese
Journal:  Cannabis Cannabinoid Res       Date:  2020-12-31

3.  Transcriptomic analysis of brain tissues identifies a role for CCAAT enhancer binding protein β in HIV-associated neurocognitive disorder.

Authors:  Saranya Canchi; Mary K Swinton; Robert A Rissman; Jerel Adam Fields
Journal:  J Neuroinflammation       Date:  2020-04-11       Impact factor: 8.322

4.  Cocaine Use Disorder Is Associated With Changes in Th1/Th2/Th17 Cytokines and Lymphocytes Subsets.

Authors:  Aline Zaparte; Jaqueline B Schuch; Thiago W Viola; Talita A S Baptista; Amanda Stephanie Beidacki; Carine H do Prado; Breno Sanvicente-Vieira; Moisés E Bauer; Rodrigo Grassi-Oliveira
Journal:  Front Immunol       Date:  2019-10-15       Impact factor: 7.561

Review 5.  Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities.

Authors:  Mark D Namba; Jonna M Leyrer-Jackson; Erin K Nagy; M Foster Olive; Janet L Neisewander
Journal:  Front Neurosci       Date:  2021-04-15       Impact factor: 4.677

6.  Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial.

Authors:  Jean-François Cailhier; Didier Jutras-Aswad; Florence Morissette; Violaine Mongeau-Pérusse; Elie Rizkallah; Paméla Thébault; Stéphanie Lepage; Suzanne Brissette; Julie Bruneau; Simon Dubreucq; Emmanuel Stip
Journal:  Neuropsychopharmacology       Date:  2021-07-30       Impact factor: 7.853

7.  Small RNA sequencing of extracellular vesicles identifies circulating miRNAs related to inflammation and oxidative stress in HIV patients.

Authors:  Sukrutha Chettimada; David R Lorenz; Vikas Misra; Steven M Wolinsky; Dana Gabuzda
Journal:  BMC Immunol       Date:  2020-11-11       Impact factor: 3.615

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.